MNOV Medicinova, Inc.

Fundamentals / CIK 0001226616 / USD

Medicinova, Inc. reported $410K in revenue and a net loss of $10.55M for the fiscal year ended December 31, 2025, with a -2814.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MNOV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$5.53M$2.76M$0-$14.06MFY 2016 Net Income: -$10.87M2016FY 2017 Net Income: -$11.16M2017FY 2018 Net Income: -$14.68M2018FY 2019 Net Income: -$12.94M2019FY 2020 Net Income: -$13.85M2020FY 2021 Revenue: $4.04MFY 2021 Net Income: -$10.13M2021FY 2022 Net Income: -$14.07M2022FY 2023 Revenue: $1.00MFY 2023 Net Income: -$8.57M2023FY 2024 Net Income: -$11.05M2024FY 2025 Revenue: $410KFY 2025 Net Income: -$12.00M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $410K -- $1.00M -- $4.04M -- -- -- -- --
Research & Development $6.70M $6.80M $5.30M $8.70M $8.10M $7.10M $5.70M $5.30M $3.90M $3.10M
Selling, General & Admin $6.54M -- -- -- -- -- -- -- -- --
Total Operating Expenses $13.69M $12.68M $10.90M $14.63M $14.25M $14.18M $14.03M $15.59M $13.03M $10.88M
Operating Income -$13.28M -$12.68M -$9.90M -$14.63M -$10.22M -$14.18M -$14.03M -$15.59M -$13.03M -$10.88M
EBITDA -$13.26M -$12.65M -$9.88M -$14.61M -$10.19M -$14.16M -$14.01M -$15.56M -$13.00M -$10.87M
Interest Income $1.30M $1.67M $1.83M $810K $144K $361K $1.15M $940K $146K $67K
Interest Expense -- -- -- -- -- -- -- -- $298 $454
Income Before Tax -$11.99M -$11.04M -$8.57M -$14.07M -$10.13M -$13.86M -$12.93M -$14.67M -$12.91M -$10.86M
Income Tax Expense $6.0K $5.5K $3.0K $2.8K $2.6K -$1.6K $13K $5.3K -$1.74M $3.8K
Net Income -$12.00M -$11.05M -$8.57M -$14.07M -$10.13M -$13.85M -$12.94M -$14.68M -$11.16M -$10.87M
Basic EPS -$0.24 -$0.23 -$0.17 -$0.29 -$0.21 -$0.31 -$0.30 -$0.36 -$0.32 -$0.33
Diluted EPS -$0.24 -$0.23 -$0.17 -$0.29 -$0.21 -$0.31 -$0.30 -$0.36 -$0.32 -$0.33
Basic Shares Outstanding 49.1M 49.0M 49.0M 49.0M 48.6M 44.4M 43.2M 41.1M 35.1M 33.0M
Diluted Shares Outstanding 49.1M 49.0M 49.0M 49.0M 48.6M 44.4M 43.2M 41.1M 35.1M 33.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $139K $458K $187K -- $123K $135K -- --
Research & Development $1.10M $900K $1.20M $1.40M $1.50M $2.00M $1.70M $1.80M
Selling, General & Admin $1.95M $1.97M $1.76M -- $1.92M $1.55M -- --
Total Operating Expenses $3.20M $3.00M $3.02M $3.24M $3.50M $3.74M $3.20M $3.18M
Operating Income -$3.06M -$2.54M -$2.84M -$3.09M -$3.38M -$3.61M -$3.20M -$3.18M
EBITDA -$3.06M -$2.54M -$2.83M -$3.09M -$3.38M -$3.60M -$3.20M -$3.18M
Interest Income $219K $232K $253K $302K $341K $325K $336K $390K
Net Income -$2.84M -$2.31M -$2.59M -$2.80M -$3.05M -$3.28M -$2.86M -$2.81M
Basic EPS -$0.06 -$0.05 -$0.05 -- -$0.06 -$0.07 -$0.06 --
Diluted EPS -$0.06 -$0.05 -$0.05 -- -$0.06 -$0.07 -$0.06 --
Basic Shares Outstanding 49.4M 49.2M 49.2M -- 49.0M 49.0M 49.0M --
Diluted Shares Outstanding 49.4M 49.2M 49.2M -- 49.0M 49.0M 49.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $30.81M $40.36M $51.00M $18.51M $71.43M $60.04M $63.79M $62.31M $27.99M $24.12M
Short-Term Investments -- -- -- $39.98M -- -- -- -- -- --
Cash & Short-Term Investments $30.81M $40.36M $51.00M $58.49M $71.43M $60.04M $63.79M $62.31M $27.99M $24.12M
Accounts Receivable, Net $0 $0 -- -- -- -- -- -- -- --
Total Current Assets $30.99M $41.07M $51.17M $58.99M $72.01M $60.72M $64.30M $62.76M $28.33M $24.70M
Property, Plant & Equipment, Net $8.3K $26K $46K $45K $58K $56K $41K $53K $63K $91K
Goodwill $9.60M $9.60M $9.60M $9.60M $9.60M $9.60M $9.60M $9.60M $9.60M $9.60M
Other Non-Current Assets $19K $19K $74K $93K $115K $75K $460K $11K $11K --
Total Non-Current Assets $14.61M $14.80M $15.10M $15.17M $15.40M $14.70M $14.90M $14.46M $15.09M $15.11M
Total Assets $45.60M $55.88M $66.27M $74.15M $87.41M $75.42M $79.21M $77.22M $43.42M $39.81M
Accounts Payable $625K $1.10M $1.00M $425K $403K $617K $451K $617K $1.52M $367K
Deferred Revenue (Current) $370K -- -- -- -- -- -- -- -- --
Total Current Liabilities $3.80M $2.96M $3.28M $3.19M $2.83M $2.19M $2.23M $2.19M $2.88M $1.63M
Deferred Revenue (Non-Current) -- -- -- -- -- $1.69M $1.69M $1.69M $1.69M $1.69M
Other Non-Current Liabilities $17K $211K $411K $524K $695K $2.7K $186K $27K -- --
Total Non-Current Liabilities $219K $413K $612K $725K $896K $1.90M $2.08M $1.92M $1.90M $3.65M
Total Liabilities $4.02M $3.37M $3.89M $3.91M $3.73M $4.09M $4.31M $4.12M $4.78M $5.28M
Total Debt (incl. Leases) $211K $405K $627K $681K $827K $189K $399K -- -- --
Common Stock $49K $49K $49K $49K $49K $45K $44K $42K $36K $35K
Retained Earnings -$438.7M -$426.8M -$415.7M -$407.1M -$393.1M -$382.9M -$369.1M -$356.1M -$341.5M -$330.3M
Accumulated Other Comp. Income -$127K -$135K -$118K -$115K -$99K -$88K -$93K -$93K -$95K -$96K
Total Stockholders' Equity $41.59M $52.50M $62.38M $70.24M $83.68M $71.33M $74.89M $73.11M $38.64M $34.53M
Total Equity $41.59M $52.50M $62.38M $70.24M $83.68M $71.33M $74.89M $73.11M $38.64M $34.53M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $29.26M $25.42M $27.33M $30.81M $32.56M $34.26M $36.57M $40.36M
Cash & Short-Term Investments $29.26M $25.42M $27.33M $30.81M $32.56M $34.26M $36.57M $40.36M
Accounts Receivable, Net $601K $0 $245K $0 $0 $135K -- $0
Total Current Assets $30.23M $25.92M $28.15M $30.99M $32.92M $35.12M $37.68M $41.07M
Property, Plant & Equipment, Net $6.5K $9.8K $15K $8.3K $13K $15K $20K $26K
Goodwill $9.60M $9.60M $9.60M $9.60M $9.60M $9.60M $9.60M $9.60M
Other Non-Current Assets $19K $0 $0 $19K $19K $19K $19K $19K
Total Non-Current Assets $15.01M $14.51M $14.56M $14.61M $14.66M $14.70M $14.75M $14.80M
Total Assets $45.24M $40.43M $42.70M $45.60M $47.58M $49.82M $52.43M $55.88M
Accounts Payable $900K $951K $852K $625K $746K $569K $719K $1.10M
Deferred Revenue (Current) $432K $0 $428K $370K $522K -- -- --
Total Current Liabilities $3.46M $2.96M $3.10M $3.80M $3.34M $2.65M $2.13M $2.96M
Other Non-Current Liabilities $490K $0 $0 $17K $74K $117K $165K $211K
Total Non-Current Liabilities $692K $202K $202K $219K $276K $319K $367K $413K
Total Liabilities $4.15M $3.16M $3.30M $4.02M $3.61M $2.97M $2.50M $3.37M
Total Debt (incl. Leases) $591K $117K $165K $211K $255K $302K $355K $405K
Common Stock $51K $49K $49K $49K $49K $49K $49K $49K
Retained Earnings -$446.5M -$443.6M -$441.3M -$438.7M -$435.9M -$432.9M -$429.6M -$426.8M
Accumulated Other Comp. Income -$127K -$127K -$128K -$127K -$127K -$127K -$130K -$135K
Total Stockholders' Equity $41.09M $37.27M $39.41M $41.59M $43.96M $46.86M $49.93M $52.50M
Total Equity $41.09M $37.27M $39.41M $41.59M $43.96M $46.86M $49.93M $52.50M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$12.00M -$11.05M -$8.57M -$14.07M -$10.13M -$13.85M -$12.94M -$14.68M -$11.16M -$10.87M
Depreciation & Amortization $20K $21K $20K $18K $26K $21K $24K $26K $28K $14K
Stock-Based Compensation $829K $1.19M $711K $643K $1.72M $3.18M $4.11M $6.33M $4.47M $3.97M
Operating Cash Flow -$9.81M -$10.64M -$7.43M -$12.91M -$9.38M -$10.83M -$9.12M -$9.11M -$6.92M -$6.55M
Capital Expenditure -$2.9K -$895 -$21K -$5.0K -$29K -$36K -$11K -$10K -- -$84K
Free Cash Flow -$9.81M -$10.64M -$7.45M -$12.92M -$9.41M -$10.86M -$9.14M -$9.12M -- -$6.63M
Investing Cash Flow -$2.9K -$697 $39.91M -$40.01M -$29K -$36K -$11K $626K -- -$84K
Common Stock Issued $244K $0 -- -- -- -- -- -- -- $88K
Financing Cash Flow $244K $0 -- $7.9K $20.78M $7.11M $10.62M $42.81M $10.80M $8.67M
Net Change in Cash -$9.55M -$10.64M $32.49M -$52.93M $11.39M -$3.76M $1.48M $34.32M $3.87M $2.04M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.84M -$2.31M -$2.59M -$2.80M -$3.05M -$3.28M -$2.86M -$2.81M
Depreciation & Amortization $3.4K $5.0K $4.3K $4.6K $5.3K $5.1K $5.2K $5.2K
Stock-Based Compensation $431K $177K $408K $181K $158K $205K $286K $264K
Change in Receivables -$601K $245K -$245K -- $135K -$135K $0 --
Operating Cash Flow -$2.39M -$1.92M -$3.47M -$2.02M -$1.70M -$2.31M -$3.78M -$1.93M
Capital Expenditure $0 $0 -$11K $0 -$2.9K $0 $0 --
Free Cash Flow -$2.39M -$1.92M -$3.48M -$2.02M -$1.71M -$2.31M -$3.78M --
Investing Cash Flow $0 $0 -$11K $0 -$2.9K $0 $0 --
Net Change in Cash $3.84M -$1.91M -$3.48M -$1.76M -$1.70M -$2.31M -$3.79M -$1.92M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -3242.5% -- -990.0% -- -253.0% -- -- -- -- --
Net Profit Margin -2928.8% -- -857.2% -- -251.0% -- -- -- -- --
Return on Equity (ROE) -28.9% -21.0% -13.7% -20.0% -12.1% -19.4% -17.3% -20.1% -28.9% -31.5%
Return on Assets (ROA) -26.3% -19.8% -12.9% -19.0% -11.6% -18.4% -16.3% -19.0% -25.7% -27.3%
Current Ratio 8.16x 13.88x 15.61x 18.51x 25.42x 27.67x 28.86x 28.63x 9.83x 15.16x
Quick Ratio 8.11x 13.64x 15.55x 18.35x 25.21x 27.36x 28.63x 28.43x 9.72x 14.80x
Debt to Equity 0.01x 0.01x 0.01x 0.01x 0.01x 0.00x 0.01x -- -- --
10Y Revenue / Share Growth -- -- +12856.7% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -25.7% -28.9% -29.7% -28.9% -27.3% -25.2% -22.3% -21.0%
Return on Assets (ROA) -23.3% -26.6% -27.4% -26.3% -25.2% -23.7% -21.3% -19.8%
Current Ratio 8.75x 8.75x 9.09x 8.16x 9.86x 13.26x 17.66x 13.88x
Quick Ratio 8.64x 8.58x 8.91x 8.11x 9.76x 12.99x 17.14x 13.64x
Debt to Equity 0.01x 0.00x 0.00x 0.01x 0.01x 0.01x 0.01x 0.01x
Revenue Growth (YoY) +12.4% +240.6% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001226616) · from December 31, 2005 Data through September 30, 2026 · synced Nov 20, 2026, 05:51 UTC · Open in terminal